Atea Pharmaceuticals, Inc. (AVIR) Capital expenditures 2019–2023
Atea Pharmaceuticals, Inc. (AVIR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.9MFY2023 · since FY2019: $12,000 → $1.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | $1.9M | +48475.0% |
| FY2022 | $4,000 | -84.6% |
| FY2021 | $26,000 | +1200.0% |
| FY2020 | $2,000 | -83.3% |
| FY2019 | $12,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice